Lyell Immunopharma, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Lyell Immunopharma, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q3 2024.
  • Lyell Immunopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 257M shares, a 1.86% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 257M +4.69M +1.86% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 256M +4.92M +1.96% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 255M +5.32M +2.13% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 254M +4.39M +1.76% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 252M +2.63M +1.06% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 251M +3.92M +1.59% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 250M +4.19M +1.71% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 250M +6.83M +2.81% Dec 31, 2022 10-K 2024-02-28
Q3 2022 249M +9.45M +3.94% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 247M +8.56M +3.59% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 245M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 243M +227M +1459% Dec 31, 2021 10-K 2023-02-28
Q3 2021 240M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 239M Jun 30, 2021 10-Q 2021-08-12
Q4 2020 15.6M Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.